Reply to: Comments on “The diagnostic potential of urinary volatile organic compounds for colorectal neoplasia in Lynch syndrome—A prospective longitudinal study”
International Journal of Cancer · 15.07.2026 · 159 (2) · 540-541
DOI: 10.1002/ijc.70450 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Cancer, online erschienen am 08.04.2026. Verfasst von Elsa L S A van Liere und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
We appreciate the interest expressed by Koulaouzidis, Marlicz and Arasaradnam in our recent prospective longitudinal study, which evaluated the potential of urinary volatile organic compounds (VOCs) as non-invasive, patient-friendly biomarkers to guide optimal colonoscopy intervals in Lynch syndrome, aiming to reduce colonoscopy burden and postcolonoscopy colorectal cancer (CRC) rates. 1 Our study demonstrated that diagnostic accuracy for any type of colorectal neoplasia — comprising mostly non-advanced adenomas — in urine was poor for FAIMS and moderate for GC-IMS (FAIMS: 74% sensitivity, 42% specificity, 0.55 AUC; GC-IMS: 65% sensitivity, 70% specificity, 0.66 AUC). On the contrary, diagnostic accuracy of faecal VOCs in our similar study was poor for GC-IMS and moderate for FAIMS (GC-IMS: 84% sensitivity, 28% specificity, 0.51 AUC; FAIMS: 88% sensitivity, 44% specificity, 0.70 AUC). 2 The current study analysed both faeces and urine with GC-IMS in a subset of individuals, showing considerably lower sensitivity to detect colorectal neoplasia by urinary VOCs compared to faecal VOCs. However, this result should be interpreted with caution because it may have been biased by the small sample size (50 individuals) as well as by differences in storage duration and temperature between urine and faeces samples. Moreover, we could not evaluate if diagnostic accuracy differs between faecal and urinary VOCs when analysed by systems other than GC-IMS. Considering urine has significant clinical benefits over faeces as it is more patient-friendly and allows on-demand collection, larger studies should validate whether faecal VOCs outperform urinary VOCs in
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, The Netherlands.
ORCID-Profile: Elsa L S A van Liere
Zitieren
APA
van Liere, E. L. S. A., Ramsoekh, D., & de Boer, N. K. H. (2026). Reply to: Comments on “The diagnostic potential of urinary volatile organic compounds for colorectal neoplasia in Lynch syndrome—A prospective longitudinal study”. International Journal of Cancer, 159(2), 540-541. https://doi.org/10.1002/ijc.70450
Vancouver
van Liere ELSA, Ramsoekh D, de Boer NKH. Reply to: Comments on “The diagnostic potential of urinary volatile organic compounds for colorectal neoplasia in Lynch syndrome—A prospective longitudinal study”. International Journal of Cancer. 2026;159(2):540-541. doi:10.1002/ijc.70450
BibTeX
@article{vanLiere2026,
author = {van Liere, Elsa L S A and Ramsoekh, Dewkoemar and de Boer, Nanne K H},
title = {Reply to: Comments on “The diagnostic potential of urinary volatile organic compounds for colorectal neoplasia in Lynch syndrome—A prospective longitudinal study”},
journal = {International Journal of Cancer},
year = {2026},
volume = {159},
number = {2},
pages = {540--541},
doi = {10.1002/ijc.70450}
}
EUVIMED